Altre lingue Enanta Pharmaceuticals, Inc.

Azioni

ENTA

US29251M1062

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 18/04/2024			Variaz. 5gg	Var. 1 gen.
13,23 ^USD	-5,50%		-21,01%	+40,60%

09/02	ENANTA PHARMACEUTICALS, INC. : per Oppenheimer è Neutral	ZM
07/02	Transcript : Enanta Pharmaceuticals, Inc., Q1 2024 Earnings Call, Feb 07, 2024

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024	17/04
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference	06/03
Earnings Flash (ENTA) ENANTA PHARMACEUTICALS Reports Q1 Revenue $18M, vs. Street Est of $21.9M	07/02
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot	07/02
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET	07/02
Enanta Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	07/02
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023	31/01
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference	04/01
Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03/01
Enanta Pharmaceuticals, Inc. Announces Retirement of Nathaniel S. Gardiner as Senior Vice President and General Counsel, Effective on or Before March 31, 2024	26/12
Enanta Pharmaceuticals, Inc.(NasdaqGS:ENTA) dropped from NASDAQ Biotechnology Index	15/12
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	24/11
Sector Update: Health Care	24/11
Enanta Pharmaceuticals Files $150 Million Mixed Shelf	24/11
Enanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference	22/11
Enanta Pharmaceuticals: Fiscal Q4 Earnings Snapshot	20/11
Earnings Flash (ENTA) ENANTA PHARMACEUTICALS Reports Q4 Revenue $18.9M, vs. Street Est of $17.5M	20/11
Enanta Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	20/11
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2023, with Webcast and Conference Call Today at 4:30 p.m. ET	20/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Enanta Pharmaceuticals, Inc.

Azioni

ENTA

US29251M1062

Altre lingue

Filtri